Collectively Improving the Standard of Breast Cancer Treatment at ASBrS 2018

About the American Society of Breast Surgeons (ASBrS)

In the organization’s own words, “The American Society of Breast Surgeons, the primary leadership organization for general surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. This mission is accomplished by providing a forum for the exchange of ideas and by promoting education, research, and the development of advanced surgical techniques. Founded in 1995, the Society has grown to more than 3000 members in the United States and 35 countries throughout the world.”

The Society’s Annual Meeting, May 2-6, 2018 in Orlando, is the breast cancer community’s greatest opportunity to connect, collaborate and collectively advance the standard of care for tens of thousands of breast cancer patients.

We want physicians interested in reducing positive margins and improving the patient experience to visit us at booth #101 to discuss MarginProbe’s ability to detect microscopic cancer intraoperatively and review the latest clinical data supporting its use.  We want attendees to appreciate the value of MarginProbe in significantly reducing the risk of positive margins thereby preventing additional surgeries. As a result, patients avoid disruption to their adjuvant care plan, reduce the risks and costs associated with additional surgeries and return to their lives prior to their cancer diagnosis.

MarginProbe will also be discussed in the Wednesday May 2nd 7am – 4pm: Beginner and Intermediate Oncoplastic Breast Surgery Skills Courses with Cadaver Lab with Drs. Dennis Holmes and Julie Reiland.

You can find the MarginProbe team throughout ASBrS 2018 at booth #101.

Posted in